Display prices in:
⚠ FDA NOTICE: These products are NOT FDA approved for human use. Sold for research purposes only. Not for human consumption.
🎟 Have a code?

Research Compound Catalog

Browse our planned peptide formulations. None are currently available for purchase.

⚠ Reminder: These products are NOT FDA approved and cannot be purchased at this time. Prices shown are projected retail prices for when approval is obtained.
Awaiting product image

Tesamorelin

$103.60 USD

Vial Size: 10 mg

Stabilized GHRH analog. Strong visceral fat reduction; FDA-approved for HIV-lipodystrophy.

SKU: PP-TES-10 Category:

Description

Tesamorelin – 10 mg

Tesamorelin is a stabilized GHRH (growth hormone releasing hormone) analog with ~30 minute half-life. FDA-approved as Egrifta for HIV-associated lipodystrophy due to its potent visceral fat-reduction effects.

Common Applications:

  • Visceral (abdominal) fat reduction
  • IGF-1 elevation via natural GH pulse
  • Lean mass support
  • Mid-life body recomposition

Reference Dosing:

1-2 mg subQ daily before bed. Higher dosing range than CJC-1295 due to different receptor kinetics.

Cycle:

8-12 weeks on, 4 weeks off. Bloodwork (IGF-1, fasting glucose) recommended.

Reviews

There are no reviews yet.

Be the first to review “Tesamorelin”

Your email address will not be published. Required fields are marked *

Important Notice

These products are NOT currently FDA approved.

The peptide compounds described on this site are for informational and research purposes only. They are not intended to diagnose, treat, cure, or prevent any disease.

The information provided is based on current scientific research and literature regarding peptide compounds. These products are presented as a preview of what may become available pending FDA regulatory approval.

Always consult with a qualified healthcare professional before starting any new supplement or wellness program.

Related products